Kepos Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Kepos Capital’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,000	Closed	-$4.98M	–	286
2023 Q3	$4.98M	Hold	25,000	–	–	0.88%	25
2023 Q2	$7.13M	Buy	+25,000	New	+$6.94M	1.31%	20

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kepos Capital's SWAV Position: Q4 2023 in Review

Kepos Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 25,000 shares — an estimated $4.98M sold.

Kepos Capital first reported a position in SWAV in Q2 2023 and held it in 2 quarters. The position peaked at $7.13M in Q2 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

Kepos Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Kepos Capital sold 25,000 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $4.98M.
Kepos Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Kepos Capital's Shockwave Medical, Inc. Common Stock position peaked at $7.13M in Q2 2023.
427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Kepos Capital's 13F filing for Q4 2023, filed 12 Feb 2024.